stAAAble Trial: Nectero EAST System for Abdominal Aortic Aneurysms - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if the Nectero EAST System® (the study procedure) is a safe and effective option for treating abdominal aortic aneurysms that are small to medium in size.
Abdominal Aortic Aneurysm (AAA)
Who Can Participate in the Study?
Adults ages 21-85 who:
- Are diagnosed with an AAA that is small to mid-size
- Are able and willing to have required follow-up clinic visits including CT scans for up to 5 years
For more information, contact the study team at frank.benedetti@duke.edu.
What is Involved?
If you choose to join this study, we will examine your AAA using a computerized tomography (CT) scan to see if you are right for the procedure. If you are eligible to take part, you will get a random assignment (like a coin flip) to be in the study treatment group or the control group (non-study treatment group). If you are selected for the study treatment group, you are going to have the study procedure and be followed for 5 years. If you are selected for the control group, as part of normal care, you will undergo CT scans and be followed for 5 years.
Study Details
